The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Curia, a contract research, development and manufacturing organization, announced a collaboration with Corning Incorporated to expand and accelerate ...
read more
Northwest Biotherapeutics and Advent BioServices, a leading contract development and manufacturing organization (CDMO) based in the UK, jointly ...
read more
Wednesday, March 15, 2023
Artisan Bio announced an extension of its research collaboration with Takeda which leverages Artisan's genome editing technology. The amended ...
read more
BioMarin Pharmaceutical Inc. announced that it received notice from the FDA that the agency has extended review of the company's Biologics License ...
read more
Friday, February 24, 2023
Porton Advanced Solutions Ltd. and Yinjia (Shanghai) Biosciences Co., Ltd. have announced a strategic partnership to accelerate the development and ...
read more
Wednesday, February 22, 2023
Ajinomoto Bio-Pharma Services, a leading provider of biopharmaceutical contract development and manufacturing services, has successfully developed a ...
read more
Biognosys AG and Bruker Corporation announced a strategic partnership, in which Bruker has made a majority-ownership investment in Biognosys.
read more
Tuesday, January 03, 2023
Datar Cancer Genetics Inc announced today that the US Food and Drug Administration (FDA) has granted 'Breakthrough Device Designation' for its '...
read more
Tuesday, December 13, 2022
Wave Life Sciences Ltd. and GSK plc announced a strategic collaboration to advance oligonucleotide therapeutics, including Wave’s preclinical RNA ...
read more
Wednesday, December 07, 2022
MilliporeSigma has acquired Massachusetts-based Erbi Biosystems, a developer of the 2 ml micro-bioreactor platform technology, known as the "Breez™". ...
read more
Tuesday, December 06, 2022
Fraunhofer IZI, one of Europe’s leading manufacturers of cell and gene therapies for clinical trials, intends to digitalize its manufacturing ...
read more
Monday, November 28, 2022
BioPharma Dynamics is expanding their portfolio for the Cell & Gene Therapy market to offer a range of chemically defined T-Cell Media, DMSO-Free ...
read more
Thursday, November 17, 2022
The FDA approved the second interchangeable biosimilar insulin product to Lantus (insulin glargine), Eli Lilly’s Rezvoglar (insulin glargine-aglr).
read more
QBiotics Group Limited has been granted approval of its Investigational New Drug (IND) application by the FDA for lead oncology molecule, tigilanol ...
read more
Bristol Myers Squibb announced that the European Medicines Agency (EMA) has validated its type II variation application for extension of the ...
read more